The cancer diagnostics company is hours away from losing funding for its tests through the US Medicare system.
Listed bank expects ongoing challenging economic conditions in the second half.
Revenues were lower for iron ore and coking coal despite higher production.
The listed bank now expects net profit between $2m and $5m in first half.
The Australian-owned company’s underlying earnings have fallen 88%.
Listed transport company reports solid revenue and profit growth in half year.
Managing director indicates potential for capital return after executing investment strategy.
Revenue and profit grows at infant formula marketer, but no news on deployment of $1b cash balance.
The wool carpet maker has initiated strategic review amid buyer interest.
The ASX-listed company behind a biomass project needs more than $300m to develop a plant at Kawerau.